Induction of hippocampal neurogenesis by a tolerogenic peptide that ameliorates lupus manifestations

Alona Telerman; Smadar Lapter; Amir Sharabi; Heidy Zinger; Edna Mozes

doi:10.1016/j.jneuroim.2010.11.001

Induction of hippocampal neurogenesis by a tolerogenic peptide that ameliorates lupus manifestations

Alona Telerman, Smadar Lapter, Amir Sharabi, Heidy Zinger, Edna Mozes^*

^*Corresponding author for this work

Weizmann Institute of Science

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

To determine the effect of the tolerogenic peptide hCDR1 on hippocampal neurogenesis, we treated SLE-afflicted (NZBxNZW)F1 mice with hCDR1 (once a week for 10. weeks). The treatment resulted in the up-regulation of neurogenesis in the dentate gyrus and restored the NeuN immunoreactivity in brain hippocampi of the mice in association with increased gene expression of IGF-1, NGF and BDNF. Furthermore, hCDR1 treatment significantly up-regulated p-ERK and p-Akt that are suggested to be key components in mediating growth factor-induced neurogenesis. The observed effects of hCDR1 on hippocampal-neurogenesis and on associated signaling pathways suggest a potential role for hCDR1 in CNS lupus.

Original language	English
Pages (from-to)	151-157
Number of pages	7
Journal	Journal of Neuroimmunology
Volume	232
Issue number	1-2
DOIs	https://doi.org/10.1016/j.jneuroim.2010.11.001
State	Published - Mar 2011
Externally published	Yes

Keywords

A model of systemic lupus erythematosus
A tolerogenic peptide
ERK and Akt pathways
Growth and neurotrophic factors
Hippocampal neurogenesis

Access to Document

10.1016/j.jneuroim.2010.11.001

Cite this

@article{cba0068252834b3a8f247c6361d8624d,

title = "Induction of hippocampal neurogenesis by a tolerogenic peptide that ameliorates lupus manifestations",

abstract = "To determine the effect of the tolerogenic peptide hCDR1 on hippocampal neurogenesis, we treated SLE-afflicted (NZBxNZW)F1 mice with hCDR1 (once a week for 10. weeks). The treatment resulted in the up-regulation of neurogenesis in the dentate gyrus and restored the NeuN immunoreactivity in brain hippocampi of the mice in association with increased gene expression of IGF-1, NGF and BDNF. Furthermore, hCDR1 treatment significantly up-regulated p-ERK and p-Akt that are suggested to be key components in mediating growth factor-induced neurogenesis. The observed effects of hCDR1 on hippocampal-neurogenesis and on associated signaling pathways suggest a potential role for hCDR1 in CNS lupus.",

keywords = "A model of systemic lupus erythematosus, A tolerogenic peptide, ERK and Akt pathways, Growth and neurotrophic factors, Hippocampal neurogenesis",

author = "Alona Telerman and Smadar Lapter and Amir Sharabi and Heidy Zinger and Edna Mozes",

year = "2011",

month = mar,

doi = "10.1016/j.jneuroim.2010.11.001",

language = "אנגלית",

volume = "232",

pages = "151--157",

journal = "Journal of Neuroimmunology",

issn = "0165-5728",

publisher = "Elsevier B.V.",

number = "1-2",

}

TY - JOUR

T1 - Induction of hippocampal neurogenesis by a tolerogenic peptide that ameliorates lupus manifestations

AU - Telerman, Alona

AU - Lapter, Smadar

AU - Sharabi, Amir

AU - Zinger, Heidy

AU - Mozes, Edna

PY - 2011/3

Y1 - 2011/3

N2 - To determine the effect of the tolerogenic peptide hCDR1 on hippocampal neurogenesis, we treated SLE-afflicted (NZBxNZW)F1 mice with hCDR1 (once a week for 10. weeks). The treatment resulted in the up-regulation of neurogenesis in the dentate gyrus and restored the NeuN immunoreactivity in brain hippocampi of the mice in association with increased gene expression of IGF-1, NGF and BDNF. Furthermore, hCDR1 treatment significantly up-regulated p-ERK and p-Akt that are suggested to be key components in mediating growth factor-induced neurogenesis. The observed effects of hCDR1 on hippocampal-neurogenesis and on associated signaling pathways suggest a potential role for hCDR1 in CNS lupus.

AB - To determine the effect of the tolerogenic peptide hCDR1 on hippocampal neurogenesis, we treated SLE-afflicted (NZBxNZW)F1 mice with hCDR1 (once a week for 10. weeks). The treatment resulted in the up-regulation of neurogenesis in the dentate gyrus and restored the NeuN immunoreactivity in brain hippocampi of the mice in association with increased gene expression of IGF-1, NGF and BDNF. Furthermore, hCDR1 treatment significantly up-regulated p-ERK and p-Akt that are suggested to be key components in mediating growth factor-induced neurogenesis. The observed effects of hCDR1 on hippocampal-neurogenesis and on associated signaling pathways suggest a potential role for hCDR1 in CNS lupus.

KW - A model of systemic lupus erythematosus

KW - A tolerogenic peptide

KW - ERK and Akt pathways

KW - Growth and neurotrophic factors

KW - Hippocampal neurogenesis

UR - http://www.scopus.com/inward/record.url?scp=79952248042&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2010.11.001

DO - 10.1016/j.jneuroim.2010.11.001

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 21129786

AN - SCOPUS:79952248042

SN - 0165-5728

VL - 232

SP - 151

EP - 157

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

IS - 1-2

ER -

Induction of hippocampal neurogenesis by a tolerogenic peptide that ameliorates lupus manifestations

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this